Scipher Medicine to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Chief Financial Officer John Strumbos will participate in the virtual 11th Annual SVB Leerink Global Healthcare Conference, hosting investor meetings on Tuesday, February 15.
About Scipher Medicine®
Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectra™, our proprietary network medicine platform, we commercialize tests revealing a person’s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases. Visit http://www.sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.
Contacts
Media Relations
Molly Johnson
Director, Corporate Communications
PR@Scipher.com
518-423-5907
Investor Relations
John Strumbos, Ph.D., MBA
Chief Financial Officer
IR@scipher.com
Editor Details
-
Company:
- Businesswire
